Dissecting OGT’s TPR domain to identify determinants of cellular function
Proceedings of the National Academy of Sciences · 28.05.2024 · 121 (22)
DOI: 10.1073/pnas.2401729121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.05.2024. Verfasst von Sarah C Potter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115. Hauptthemen laut MEDLINE: N-Acetylglucosaminyltransferases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | National Institutes of Health (NIH), Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC).
Abstract (Originalsprache)
O-GlcNAc transferase (OGT) is an essential mammalian enzyme that glycosylates myriad intracellular proteins and cleaves the transcriptional coregulator Host Cell Factor 1 to regulate cell cycle processes. Via these catalytic activities as well as noncatalytic protein–protein interactions, OGT maintains cell homeostasis. OGT’s tetratricopeptide repeat (TPR) domain is important in substrate recognition, but there is little information on how changing the TPR domain impacts its cellular functions. Here, we investigate how altering OGT’s TPR domain impacts cell growth after the endogenous enzyme is deleted. We find that disrupting the TPR residues required for OGT dimerization leads to faster cell growth, whereas truncating the TPR domain slows cell growth. We also find that OGT requires eight of its 13 TPRs to sustain cell viability. OGT-8, like the nonviable shorter OGT variants, is mislocalized and has reduced Ser/Thr glycosylation activity; moreover, its interactions with most of wild-type OGT’s binding partners are broadly attenuated. Therefore, although OGT’s five N-terminal TPRs are not essential for cell viability, they are required for proper subcellular localization and for mediating many of OGT’s protein–protein interactions. Because the viable OGT truncation variant we have identified preserves OGT’s essential functions, it may facilitate their identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.
- Chemical Neurobiology Laboratory, Center for Genomic Medicine, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
- Department of Cell Biology, Blavatnik Institute of Harvard Medical School, Boston, MA 02115.
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
ORCID-Profile: Sarah C Potter, Bettine E Gibbs, Cassandra M Joiner, Joao A Paulo, Zebulon G Levine, George Q Fei, Stephen J Haggarty
Förderung
- NIGMS NIH HHS
- HHS | National Institutes of Health (NIH)
- Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
- Massachusetts General Hospital (MGH)
- National Science Foundation (NSF)
Zitieren
APA
Potter, S. C., Gibbs, B. E., Hammel, F. A., Joiner, C. M., Paulo, J. A., Janetzko, J., Levine, Z. G., Fei, G. Q., Haggarty, S. J., & Walker, S. (2024). Dissecting OGT’s TPR domain to identify determinants of cellular function. Proceedings of the National Academy of Sciences, 121(22). https://doi.org/10.1073/pnas.2401729121
Vancouver
Potter SC, Gibbs BE, Hammel FA, Joiner CM, Paulo JA, Janetzko J, et al. Dissecting OGT’s TPR domain to identify determinants of cellular function. Proceedings of the National Academy of Sciences. 2024;121(22). doi:10.1073/pnas.2401729121
BibTeX
@article{Potter2024,
author = {Potter, Sarah C and Gibbs, Bettine E and Hammel, Forrest A and Joiner, Cassandra M and Paulo, Joao A and Janetzko, John and Levine, Zebulon G and Fei, George Q and Haggarty, Stephen J and Walker, Suzanne},
title = {Dissecting OGT’s TPR domain to identify determinants of cellular function},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {22},
doi = {10.1073/pnas.2401729121}
}
EUVIMED